Sponsored Symposia 2022
Tuesday, November 22, 2022
10:45-11:15 am
Flash Talk I
Supported by Promega

Novel Bioluminescent Bioassays for the Discovery and Development of Molecular and Cellular T Cell Redirecting Therapy
Johann, Axel
11:30 am – 12:15 pm
Industry sponsored session I
Supported by Gilead

Welcome and introduction: Recent developments in CAR T cell therapy
Chair: Vucinic, Vladan (Universitätsklinikum Leipzig)
CAR T cell therapy in the treatment of relapsed/refractory NHL
Schnetzke, Ulf (Universitätsklinikum Jena)
CAR T cell therapy in the treatment of relapsed/refractory adult B-ALL
Bug, Gesine (Universitätsklinikum Frankfurt)
Panel discussion and Q&A: Patient selection, patient management and CAR T patient journey
Chair: Vucinic, Vladan (Universitätsklinikum Leipzig)
1:00-1:45 pm
Industry sponsored session II
Supported by Janssen-Cilag

Chair: Raab, Marc-Steffen (Heidelberg)
Sequence therapy after BCMA pre-therapy, integration into the overall therapy of multiple myeloma
Raab, Marc-Steffen (Heidelberg)
Kortüm, Martin (Würzburg)
Wednesday, November 23, 2022
10:45-11:15 am
Flash Talk II
Supported by Amgen

T cell engaging therapies in the treatment of Acute Lymphoblastic Leukemia (ALL)
Gökbuget, Nicola (University Hospital Frankfurt, Frankfurt, Germany)
1:00-1:45 pm
Industry sponsored session III
Supported by Bristol Myers Squibb

CAR-T-Cell therapies: personalized cancer medicine 2.0
Scheid, Christoph (Universitätsklinikum Köln)
Glaß, Bertram (Helios Klinikum Buch)